| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.072 | 0.2 |